Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2011Expert Review of Clinical ImmunologyOpen Access

The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMaja MockenhauptUniversity of Freiburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maja Mockenhaupt (2011) studied this question.

synapsesocial.com/papers/69df05c5b8d7e94566614078https://doi.org/10.1586/eci.11.66
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme1993 · 1,630 citations
  2. 2A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs2008 · 627 citations
  3. 3Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis2010 · 275 citations
  4. 4Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis2002 · 617 citations